
zzso zzso zzso treatments can result in severe infusion zzso Managing infusion reactions in the zzso setting introduces clinical and resource challenges for patients and providers, but there is little information regarding zzso management, or outcomes of severe infusion zzso This study represents one of the first attempts to describe the clinical consequences of severe infusion reactions associated with zzso zzso 

Clinic staff identified adults treated with zzso zzso or zzso who experienced a grade 3 or higher zzso infusion zzso zzso reviews from 19 zzso practice sites across the USA captured patient zzso infusion reaction management procedures, and clinical zzso 

With an average age of 62 years, the sample comprised of 76 patients who experienced a severe infusion reaction while receiving zzso zzso zzso zzso zzso zzso zzso 24), and zzso zzso zzso zzso The most common zzso medications were zzso and zzso in the zzso group and zzso zzso in the zzso zzso All zzso and the majority of zzso severe infusion reactions occurred during the first cycle of zzso zzso reaction management typically included zzso zzso and intravenous zzso Overall, zzso were hospitalized for a mean of 4 days zzso zzso zzso to zzso zzso Permanent zzso of zzso therapy occurred after the majority of zzso (79 to zzso related severe infusion zzso 

Severe infusion reactions are intensive events that present a serious challenge to patients and zzso zzso Efforts to prevent or reduce such reactions could be of great zzso 

